<< BACK TO EIGHTH GAVI BOARD MEETING

Eighth GAVI Board Meeting, Paris, 19-20 June 2002

9. Revised guidelines for optimal, effective and catalytic use of resources from "Window 3" of the Vaccine Fund

Click here to download presentation [Powerpoint, 49 kb]

Click here to download paper [Word, 40 kb]

• Window 3 resources may be appropriately used to fund R&D; efforts on improved vaccine delivery technology and reduced reliance on cold chain, with the goal of increasing access. Funding should be used to support efforts to reach 80-80 goal, including perhaps operational research addressing issues concerning immunization within the broader health sector context.
  
  
• Conflict of interest needs to be even further emphasised in the review process to ensure transparency; in some cases it may be necessary for reviewers to exclude themselves from discussions.
  
  

DECISIONS

The Board:

2.1 Approved the guidelines for use of resources from Window 3 to support the ADIP activities, with a ceiling of USD90 million over three years. Actual funding amounts will be based on the proposed workplans developed by the ADIPs.

2.2 Requested the Executive Secretary to report back to the Board on specific activities, and their budget requirements, that will be needed in the next 6 to 18 months to maintain the momentum gained through the work of the pneumococcal and rotavirus teams - while the ADIPs are being formed.

2.3 Requested additional thinking on intellectual property rights and pricing issues.

<< BACK TO EIGHTH GAVI BOARD MEETING

Download Adobe Acrobat (Required to read PDF documents)